tradingkey.logo
搜尋

Lifecore Biomedical Inc

LFCR
添加自選
5.090USD
-0.180-3.42%
收盤 07/02, 13:00美東報價延遲15分鐘
190.76M總市值
虧損本益比TTM

關於 Lifecore Biomedical Inc 公司

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc簡介

公司代碼LFCR
公司名稱Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOJosephs (Paul)
員工數量406
證券類型Ordinary Share
年結日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55318
電話19523684300
網址https://www.lifecore.com/
公司代碼LFCR
上市日期Feb 15, 1996
CEOJosephs (Paul)

Lifecore Biomedical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

常見問題

Lifecore Biomedical Inc的前五大股東是誰?

Lifecore Biomedical Inc的前五大股東如下:Mr. Paul Josephs

有多少機構持有Lifecore Biomedical Inc(LFCR)的股份?

截至2026Q1,共有225家機構持有Lifecore Biomedical Inc的股份,合計持有的股份價值約為30.56M,占公司總股份的81.48% 。與2025Q4相比,機構持股有所增加,增幅為1031462.00。

哪個業務部門對Lifecore Biomedical Inc的收入貢獻最大?

在2026Q1,Contract development and manufacturing organization ("CDMO")業務部門對Lifecore Biomedical Inc的收入貢獻最大,創收17.81M,占總收入的64.53% 。